CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories Oct 30, 2024 8:30am EDT
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development Oct 08, 2024 8:30am EDT
CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques Oct 07, 2024 11:05am EDT
CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite Stable Colorectal Cancer Aug 12, 2024 8:30am EDT
